CLAVASEPTIN 50 MG PALATABLE TABLETS FOR DOGS AND CATS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE; CLAVULANIC ACID AS POTASSIUM CLAVULANATE

Available from:

VETOQUINOL AUSTRALIA PTY LTD

Pharmaceutical form:

ORAL TABLET

Composition:

AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE ANTIBIOTIC Active 40.0 mg; CLAVULANIC ACID AS POTASSIUM CLAVULANATE ANTIBIOTIC Active 10.0 mg

Units in package:

10 Tablets; 100 Tablets; 1000 Tablets; 120 Tablets; 150 Tablets; 20 Tablets; 200 Tablets; 250 Tablets; 300 Tablets; 400 Tablets; 50 Tablets; 500 Tablets; 600 Tablets; 750 Tablets

Class:

VM - Veterinary Medicine

Therapeutic area:

ANTIBIOTIC & RELATED

Product summary:

Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [BORDETELLA BRONCHISEPTICA, CORYNEBACTERIUM SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA SPP., PASTEURELLA SPP., PROTEUS MIRABILIS, SALMONELLA, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP.]; DOG: [BORDETELLA BRONCHISEPTICA, CORYNEBACTERIUM SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA SPP., PASTEURELLA SPP., PROTEUS MIRABILIS, SALMONELLA, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP.]

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

Product Name:
APVMA Approval No:
CLAVASEPTIN 50 MG PALATABLE TABLETS FOR DOGS AND CATS
88165/120471
Label Name:
CLAVASEPTIN 50 MG PALATABLE TABLETS FOR DOGS AND CATS
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
40 mg AMOXICILLIN (as Amoxicillin trihydrate)
10 mg CLAVULANIC ACID (as Potassium Clavulanate)
Each CLAVASEPTIN 50 mg PALATABLE TABLET contains 40 mg of AMOXICILLIN
(as
Amoxicillin trihydrate) and 10 mg of CLAVULANIC ACID (as Potassium
clavulanate).
Claims:
For the treatment of bacterial infections sensitive to Clavulanic Acid
and Amoxicillin in dogs
and cats.
Clinically CLAVASEPTIN has been shown to be effective in treating a
wide range of
diseases of dogs and cats including:
• Skin diseases (including deep and superficial pyodermas)
• Urinary tract infection
• Respiratory disease (involving upper and lower respiratory tract)
• Enteritis
CLAVASEPTIN Palatable Tablets have a notably broad spectrum of
bactericidal activity
against bacteria commonly found in dogs and cats and are indicated for
the oral treatment
of bacterial infections caused by susceptible organisms.
Resistance may develop to any antimicrobial.
In vitro CLAVASEPTIN is active against a wide range of clinically
important bacteria
including:
Gram-positive
Staphylococcus spp. (including ß-lactamase producing strains)
Corynebacterium spp.
Streptococcus spp.
Gram-negative
Escherichia coli (including ß-lactamase producing strains)
Salmonella spp. (including ß-lactamase producing strains)
Bordetella bronchiseptica; Pasteurella; Proteus mirabilis and other
sensitive strains;
Klebsiella. RLP APPROVED
CLAVASEPTIN is not indicated for cases involving Pseudomonas spp.
Use as directed by prescribing veterinarian.
Net Contents:
10 [20, 50 100, 120, 150, 200, 250, 300, 400, 500, 600, 750, 1000]
Tablets
Directions for Use:
Restraints:
Contraindications:
This product is contraindicated for use in animals that are
hypersensitive to or have a
history of allergic reactions